2019 conference themes and abstract call
If you have any queries, questions or comments please get in touch
The conference focuses on the theme ‘10 years on: accelerating early diagnosis evidence into practice’, and will showcase the latest research and translation covering the entire diagnostic pathway; from screening, and public behaviour, through to optimising referral from primary to secondary care, to achieving a diagnosis.
By translating the latest evidence into policy and practice, we aim to reduce late stage diagnosis and contribute to improvements in cancer outcomes.
Our call for abstracts has now closed.
If you have any queries about the abstract submission process please contact the team.
We welcome abstracts that contribute to our understanding of the determinants and impacts of national cancer screening programmes (breast, bowel and cervical); including research into increasing uptake, risk stratification, improving implementation and examinations of the benefits and harms of screening.
We're keen to showcase research that progress our understanding of how to optimise the patient referral journey from primary to secondary care. Relevant topics to explore in this session include; assessing the implementation and impact of referral guidelines for suspected cancer (e.g. use of FIT in symptomatic patients), exploring the communication between patient and GP during consultation, safety-netting and the interface between primary and secondary care.
National and regional early diagnosis efforts continue to focus on lung cancer. The rationale is clear: Unlike the majority of cancers, survival for lung cancer has not shown much improvement since the early 1970s and we know that survival is strongly correlated with the stage that lung cancer is diagnosed. We welcome abstracts reporting findings from proactive lung screening activities and investigating the implementation and impact of the rapid cancer diagnostic and assessment pathway.
Through initiatives, like the International Cancer Benchmarking Partnership, we continue to learn how the UK cancer outcomes compare to international counterparts and what could be driving the differences. Under this theme, we welcome abstracts which showcase early diagnosis research and translation activities taking place in other countries.
Scrutiny of cancer pathways from referral to diagnosis can give insights that are key to optimising cancer early diagnosis. Across the UK there is a lot of work going into the development and implementation of innovative cancer pathways, e.g. the introduction of multi diagnostic centres. We welcome abstracts which detail the design of pathways and provide the insights into the opportunities and challenges of implementing new pathways. Profiling the emerging evidence and latest evaluation results to show effectiveness and impact of implementation.
There is a wealth of cancer data at our fingertips, which could be used to help assess the need for early diagnosis activities and the evaluation of their impact. We welcome abstracts that showcase how cancer data and metrics have been used to support, monitor and evaluate early diagnosis activities. We are also interested in abstracts which highlight novel methods to integrate, interpret or visualise data to help improve cancer outcomes.